title: Administration of Coagulation-Altering Therapy in the Patient Presenting for Oral Health and Maxillofacial Surgery.
abstract: Oral health care providers are concerned with how to manage patients prescribed coagulation-altering therapy during the perioperative/periprocedural period for dental and oral surgery interventions. Management and recommendation can be based on medication pharmacology and the clinical relevance of coagulation factor levels/deficiencies. Caution should be used with concurrent use of medications that affect other components of the clotting mechanisms; prompt diagnosis and any necessary intervention to optimize outcome is warranted. However, evidence-based data on management of anticoagulation therapy during oral and maxillofacial surgery/interventions is lacking. Therefore, clinical understanding and judgment are needed along with appropriate guidelines matching patient- and intervention-specific recommendations.
authors.affiliation: Department of Anesthesiology, Yale University School of Medicine, 333 Cedar Street, TMP 3 Library, New Haven, CT 203 785-2804, USA. Electronic address: thomas.halaszynski@yale.edu.
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Halaszynski
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced* / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006488:Hemostasis, Surgical; D006801:Humans; D054539:Medication Therapy Management; D019647:Oral Surgical Procedures; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D000925:Anticoagulants
keywords: Anticoagulation therapy; Dual-anticoagulation therapy; Hemostasis/coagulation; Oral and maxillofacial surgery; Specialty-society anticoagulation guidelines and recommendations; www.WarfarinDosing.org